Hans-Peter Hasler

Hans-Peter Hasler

Presidente presso SHIELD THERAPEUTICS PLC

Patrimonio netto: 2 M $ in data 30/04/2024

68 anni
Health Technology
Commercial Services
Finance

Profilo

Hans-Peter Hasler is the founder of Vicarius Pharma AG, which was founded in 2016.
He is currently the Chairman of HBM Healthcare Investments AG since 2009, the Non-Executive Chairman of Shield Therapeutics Plc since 2018, the Chairman of Medical Imaging Analysis Center since 2012, an Independent Director of Minerva Neurosciences, Inc. since 2017, an Independent Director of Gain Therapeutics, Inc. since 2021, and a Principal at Hph Management GmbH.
Mr. Hasler's former positions include Vice Chairman of Santhera Pharmaceuticals Holding AG from 2006 to 2011, Director of Acino International AG from 2008 to 2013, Independent Non-Executive Director of Dr. Reddy's Laboratories Ltd.
from 2016 to 2018, Managing Director of Wyeth Pharma GmbH, Director of Ferring Holding SA, Director of Ferring International Center SA, Independent Director of Celltrion, Inc., Managing Director of Wyeth Pharmaceuticals AG from 1993 to 1998, Director of Canyon Pharmaceuticals AG, Director of Aop Orphan Pharmaceuticals GmbH, Managing Director of Wyeth-lederle Pharma GmbH, Director of Dr. Reddy's Laboratories SA, Independent Non-Executive Director of Patheon NV from 2016 to 2017, Director of Rigi Healthcare AG, Chief Marketing Officer of Wyeth LLC, Executive Vice President-International of Biogen MA, Inc., Chief Operating Officer of Elan Corp.
Plc from 2012 to 2014, COO, EVP, Head-Global Neurology & International of Biogen, Inc. from 2001 to 2009, and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC from 1998 to 2001.
Mr. Hasler obtained an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/03/2023 8 641 ( 0.12% ) 2 M $ 30/04/2024
21/11/2023 5 500 000 ( 0.70% ) 92 950 $ 30/04/2024
31/03/2024 1 250 ( 0.02% ) 3 038 $ 30/04/2024
25/04/2024 0 ( -.--% ) - $ 30/04/2024

Posizioni attive di Hans-Peter Hasler

SocietàPosizioneInizio
HBM HEALTHCARE INVESTMENTS AG Presidente 01/06/2009
MINERVA NEUROSCIENCES, INC. Direttore/Membro del Consiglio 10/12/2017
SHIELD THERAPEUTICS PLC Presidente 18/06/2020
GAIN THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/01/2021
Fondatore 01/04/2016
Corporate Officer/Principal -
Medical Imaging Analysis Center Presidente 01/12/2012
Tutte le posizioni attive di Hans-Peter Hasler

Precedenti posizioni note di Hans-Peter Hasler

SocietàPosizioneFine
DR. REDDY'S LABORATORIES LIMITED Direttore/Membro del Consiglio 14/06/2018
PATHEON N.V. Direttore/Membro del Consiglio 29/08/2017
░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Hans-Peter Hasler

Formazione di Hans-Peter Hasler

Schweizerisches Institut für Betriebsökonomie AG Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hans-Peter Hasler

Relazioni

100 +

Relazioni di 1° grado

28

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
BIOGEN INC.

Health Technology

DR. REDDY'S LABORATORIES LIMITED

Health Technology

SANTHERA PHARMACEUTICALS HOLDING AG

Health Technology

CELLTRION, INC.

Health Technology

MINERVA NEUROSCIENCES, INC.

Health Technology

SHIELD THERAPEUTICS PLC

Health Technology

GAIN THERAPEUTICS, INC.

Health Technology

Aziende private20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Wyeth Pharma GmbH

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Wyeth Pharmaceuticals AG

Canyon Pharmaceuticals AG

Health Technology

Wyeth-lederle Pharma GmbH

Health Technology

Health Technology

Medical Imaging Analysis Center

Commercial Services

Commercial Services

Rigi Healthcare AG

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Hans-Peter Hasler
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA